Name:	O
___	O
Unit	O
___:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
ACE	O
Inhibitors	O
/	O
atenolol	O
/	O
nifedipine	O
/	O
NSAIDS	O
(Non-Steroidal	O
Anti-Inflammatory	O
Drug)	O
/	O
propranolol	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Bilateral	O
lower	O
extremity	O
swelling	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None.	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
F	O
with	O
non	O
ischemic	O
HFrEF	O
(EF	O
___,	O
CKD	O
stage	O
IV	O
(s/p	O
right	O
AV	O
fistula	O
___,	O
and	O
DM	O
who	O
presents	O
with	O
bilateral	O
lower	O
extremity	O
swelling.	O
Swelling	O
had	O
been	O
increasing	O
over	O
___	O
weeks,	O
slowly	O
becoming	O
painful	O
when	O
trying	O
to	O
ambulate	O
around	O
the	O
___.	O
PCP	O
and	O
nephrologists	O
recommended	O
coming	O
to	O
ED	O
for	O
evaluation.	O
___	O
major	O
diet	O
changes	O
although	O
does	O
eat	O
salty	O
food	O
regularly.	O
Adherent	O
to	O
diuretic	O
regimen,	O
with	O
___	O
changes	O
in	O
recent	O
medications	O
besides	O
Procrit.	O
___	O
chest	O
pain,	O
orthopnea,	O
palpitations,	O
fevers,	O
chills,	O
SOB,	O
dizziness,	O
nausea,	O
vomiting,	O
or	O
headaches.	O
Past	O
Medical	O
History:	O
Diastolic	O
and	O
Systolic	O
Congestive	O
Heart	O
Failure	O
___	O
class	O
III	O
Left	O
ventricular	O
diastolic	O
dysfunction	O
Cardiomyopathy	O
LVEF	O
___	O
Arthritis,	O
rheumatoid	O
Chronic	O
kidney	O
disease,	O
stage	O
IV	O
(severe)	O
DM	O
renal	O
manif	O
type	O
II,	O
uncontrolled	O
Hypertension	O
Anemia	O
secondary	O
to	O
chronic	O
renal	O
failure	O
Hypothyroidism	O
Obstructive	O
Sleep	O
Apnea	O
Carpal	O
tunnel	O
syndrome	O
Hyperparathyroidism	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
had	O
HTN,	O
passed	O
away	O
at	O
___	O
yo	O
had	O
prostate	O
CA/dementia.	O
Mother	O
had	O
HTN,	O
died	O
from	O
intracerebral	B-Intracranial_haemorrhage
hemorrhage	B-Intracranial_haemorrhage
at	O
age	O
___	O
or	O
___.	O
Siblings-	O
___	O
heart	O
disease.	O
Brother	O
died	O
from	O
esophageal	O
cancer.	O
Sister	O
x	O
1	O
had	O
a	O
stroke.	O
Physical	O
Exam:	O
===================	O
ADMISSION	O
EXAM	O
===================	O
VITALS:	O
T:	O
97.7PO	O
BP:	O
147/82	O
HR:	O
101	O
RR:	O
20	O
SO2:	O
95	O
Ra	O
General:	O
Alert,	O
oriented,	O
___	O
acute	O
distress	O
HEENT:	O
Sclerae	O
anicteric,	O
MMM,	O
oropharynx	O
clear,	O
EOMI,	O
PERRL,	O
neck	O
supple,	O
JVP	O
10,	O
___	O
LAD	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
___	O
murmurs,	O
rubs,	O
gallops	O
Lungs:	O
Clear	O
to	O
auscultation	O
bilaterally,	O
___	O
wheezes,	O
rales,	O
rhonchi	O
Abdomen:	O
Soft,	O
non-tender,	O
non-distended,	O
bowel	O
sounds	O
present,	O
___	O
organomegaly,	O
___	O
rebound	O
or	O
guarding	O
GU:	O
___	O
foley	O
Ext:	O
Warm,	O
well	O
perfused,	O
2+	O
pulses,	O
___	O
clubbing,	O
cyanosis	O
or	O
bilateral	O
2+	O
edema	O
non-pitting	O
Skin:	O
Warm,	O
dry,	O
___	O
rashes	O
or	O
notable	O
lesions.	O
Neuro:	O
CNII-XII	O
intact,	O
___	O
strength	O
upper/lower	O
extremities,	O
grossly	O
normal	O
sensation,	O
2+	O
reflexes	O
bilaterally.	O
===================	O
DISCHARGE	O
EXAM	O
===================	O
VITALS:	O
Temp:	O
98.5	O
PO	O
BP:	O
125/71	O
L	O
Lying	O
HR:	O
84	O
RR:	O
18	O
O2	O
sat:	O
98%	O
O2	O
delivery:	O
Ra	O
General:	O
Comfortable	O
appearing,	O
sitting	O
up	O
in	O
bed.	O
HEENT:	O
MMM.	O
CV:	O
JVP	O
not	O
elevated.	O
RRR,	O
___	O
murmurs.	O
Brachial	O
AV	O
fistula	O
with	O
palpable	O
thrill	O
and	O
audible	O
bruit.	O
Lungs:	O
CTAB.	O
Abd:	O
Soft,	O
non-tender	O
Ext:	O
Trace	O
edema	O
to	O
ankles	O
bilaterally,	O
L>R	O
ankle.	O
Xerosis	O
over	O
lower	O
extremities.	O
Neuro:	O
A&Ox3,	B-Delirium
intact	O
attention	O
Pertinent	O
Results:	O
===================	O
ADMISSION	O
LABS	O
===================	O
___	O
06:32PM	O
BLOOD	O
WBC-9.8	O
RBC-4.02	O
Hgb-8.0*	O
Hct-27.8*	O
MCV-69*	O
MCH-19.9*	O
MCHC-28.8*	O
RDW-21.4*	O
RDWSD-52.2*	O
Plt	O
___	O
___	O
06:32PM	O
BLOOD	O
Neuts-86.1*	O
Lymphs-7.0*	O
Monos-5.5	O
Eos-0.5*	O
Baso-0.4	O
Im	O
___	O
AbsNeut-8.39*	O
AbsLymp-0.68*	O
AbsMono-0.54	O
AbsEos-0.05	O
AbsBaso-0.04	O
___	O
06:32PM	O
BLOOD	O
Calcium-8.8	O
Phos-3.6	O
Mg-2.0	O
___	O
06:32PM	O
BLOOD	O
TSH-6.5*	O
==================	O
ADMISSION	O
IMAGING	O
==================	O
___	O
CHEST	O
(PA	O
&	O
LAT)	O
IMPRESSION:	O
___	O
acute	O
cardiopulmonary	O
process.	O
==============	O
OTHER	O
RESULTS	O
==============	O
EKG	O
___	O
NSR	O
w/	O
APCs,	O
LVH	O
by	O
AVL,	O
___	O
ischemic	O
ST	O
or	O
T	O
wave	O
changes	O
========================	O
PERTINENT	O
INPATIENT	O
LABS	O
========================	O
___	O
07:37AM	O
BLOOD	O
Glucose-92	O
UreaN-42*	O
Creat-3.2*	O
Na-146	O
K-4.0	O
Cl-108	O
HCO3-21*	O
AnGap-17	O
___	O
07:37AM	O
BLOOD	O
Calcium-8.7	O
Phos-3.7	O
Mg-1.9	O
==============	O
DISCHARGE	O
LABS	O
==============	O
___	O
07:18AM	O
BLOOD	O
Glucose-92	O
UreaN-45*	O
Creat-3.6*	O
Na-142	O
K-4.0	O
Cl-105	O
HCO3-22	O
AnGap-15	O
Brief	O
Hospital	O
Course:	O
================================	O
TRANSITIONAL	O
ISSUES:	O
================================	O
MEDICATIONS	O
CHANGED:	O
-	O
Amlodipine	O
decreased	O
from	O
10	O
mg	O
to	O
5mg	O
daily	O
-	O
Hydralazine	O
increased	O
from	O
75	O
mg	O
to	O
100	O
mg	O
TID	O
MEDICATIONS	O
STARTED:	O
-	O
Cyanocobalamin	O
1000	O
mcg	O
PO/NG	O
DAILY	O
-	O
Bisacodyl	O
5mg	O
daily	O
-	O
Polyethylene	O
glycol	O
17	O
grams	O
daily	O
PRN	O
FOR	O
PCP/NEPHROLOGY:	O
-	O
Amlodipine	O
was	O
decreased	O
from	O
10mg	O
to	O
5mg	O
due	O
to	O
bilateral	O
lower	O
extremity	O
edema.	O
Due	O
to	O
rebound	O
hypertension,	O
her	O
hydralazine	O
was	O
increased	O
from	O
75mg	O
TID	O
to	O
___	O
TID	O
with	O
good	O
effect.	O
Monitor	O
BPs	O
on	O
new	O
regimen.	O
-	O
Can	O
consider	O
adding	O
metolazone	O
every	O
other	O
day	O
to	O
torsemide	O
if	O
recurrent	O
edema.	O
-	O
Started	O
on	O
B12	O
supplementation	O
for	O
confirmed	O
low	O
level	O
(219).	O
Consider	O
rechecking	O
B12	O
levels	O
and	O
CBC	O
in	O
___	O
weeks	O
(___)	O
and	O
adjust	O
supplementation	O
as	O
needed.	O
-	O
Treated	O
with	O
IV	O
iron	O
250	O
mcg	O
x2	O
for	O
iron	O
deficiency	O
anemia	O
(TSat	O
11%).	O
Consider	O
additional	O
infusions	O
as	O
outpatient.	O
She	O
will	O
continue	O
her	O
oral	O
iron	O
supplement	O
in	O
the	O
meantime.	O
-	O
Patient	O
was	O
not	O
taking	O
levothyroxine	O
as	O
prescribed.	O
Prescribed	O
as	O
___	O
tablet	O
(87.5mcg)	O
by	O
mouth	O
6	O
days	O
a	O
week	O
and	O
1	O
full	O
tablet	O
(175mcg)	O
on	O
___.	O
However,	O
she	O
reported	O
she	O
was	O
taking	O
1	O
full	O
tablet	O
(175mcg)	O
6	O
days/week	O
and	O
2	O
tablets	O
(350mcg)on	O
___.	O
Discharged	O
on	O
dose	O
as	O
prescribed.	O
Consider	O
rechecking	O
TFTs	O
and	O
clarifying	O
dose	O
with	O
patient	O
at	O
next	O
visit.	O
Discharge	O
weight:	O
86.4	O
kg	O
(bed	O
weight)	O
Discharge	O
BUN/Cr:	O
45/3.6	O
Discharge	O
Hgb	O
7.3,	O
MCV	O
70	O
Code	O
Status:	O
Full	O
presumed	O
Name	O
of	O
health	O
care	O
proxy:	O
___	O
___:	O
daughter	O
Phone	O
number:	O
___	O
======================	O
BRIEF	O
HOSPITAL	O
COURSE:	O
======================	O
___	O
year	O
old	O
woman	O
with	O
non	O
ischemic	O
HFrEF	O
(EF	O
___,	O
CKD	O
stage	O
IV	O
(s/p	O
AV	O
fistula	O
___,	O
and	O
DM	O
who	O
presents	O
with	O
bilateral	O
lower	O
extremity	O
swelling,	O
likely	O
due	O
to	O
side	O
effect	O
of	O
amlodipine	O
as	O
well	O
as	O
HFrEF	O
exacerbation	O
due	O
to	O
worsening	O
renal	O
function.	O
Pt	O
was	O
diuresed	O
with	O
IV	O
Lasix	O
and	O
her	O
clinical	O
status	O
improved.	O
She	O
was	O
seen	O
by	O
___	O
who	O
recommended	O
___	O
rehab.	O
#	O
Bilateral	O
lower	O
extremity	O
___,	O
due	O
to:	O
#	O
Amlodipine	O
adverse	O
effect	O
#	O
Acute	O
on	O
chronic	O
systolic	O
and	O
diastolic	O
heart	O
failure	O
/	O
nonischemic	O
cardiomyopathy	O
(EF	O
___	O
The	O
patient	O
presented	O
with	O
bilateral	O
leg	O
swelling	O
and	O
mild	O
JVP	O
elevation.	O
She	O
denied	O
orthopnea,	O
shortness	O
of	O
breath,	O
or	O
chest	O
pain.	O
EKG	O
was	O
not	O
concerning	O
for	O
ischemic/cardiac	O
etiology	O
and	O
CXR	O
showed	O
___	O
cardiopulmonary	O
process.	O
___	O
edema	O
likely	O
primarily	O
due	O
to	O
side	O
effect	O
from	O
amlodipine	O
as	O
well	O
as	O
dietary	O
indiscretion.	O
Nephrology	O
was	O
consulted	O
and	O
recommended	O
IV	O
diuresis	O
with	O
100mg	O
IV	O
furosemide	O
with	O
improvement	O
in	O
her	O
clinical	O
status.	O
Her	O
amlodipine	O
was	O
decreased	O
from	O
10mg	O
to	O
5mg.	O
Given	O
elevated	O
blood	O
pressures	O
after	O
this	O
change,	O
her	O
hydralazine	O
was	O
increased	O
from	O
75mg	O
TID	O
to	O
___	O
TID.	O
She	O
was	O
continued	O
on	O
her	O
home	O
imdur	O
and	O
ivabradine,	O
and	O
losartan	O
was	O
given	O
in	O
lieu	O
of	O
home	O
irbesartan	O
(not	O
on	O
formulary).	O
She	O
was	O
restarted	O
on	O
her	O
home	O
torsemide.	O
She	O
was	O
also	O
counseled	O
on	O
the	O
importance	O
of	O
a	O
low	O
salt	O
diet.	O
Renal	O
function	O
remained	O
at	O
baseline.	O
The	O
patient	O
remained	O
hemodynamically	O
stable	O
throughout	O
her	O
hospitalization,	O
and	O
her	O
lower	O
extremity	O
edema	O
improved.	O
She	O
did	O
complain	O
of	O
pain	O
and	O
weakness	O
in	O
her	O
lower	O
extremities,	O
so	O
___	O
was	O
consulted	O
and	O
recommended	O
___	O
rehabilitation.	O
#CKD	O
stage	O
IV:	O
Recent	O
fistula	O
placed	O
___,	O
currently	O
maturing.	O
Palpable	O
thrill/audible	O
bruit	O
on	O
exam.	O
___	O
acute	O
RRT	O
needs	O
during	O
this	O
hospitalization.	O
Creatinine	O
increased	O
slightly	O
to	O
3.6	O
but	O
this	O
was	O
around	O
her	O
baseline.	O
Diuresis	O
was	O
administered	O
as	O
above.	O
Intake	O
and	O
output	O
was	O
strictly	O
monitored.	O
#	O
Chronic	O
microcytic	O
anemia,	O
due	O
to:	O
#	O
Anemia	O
of	O
chronic	O
renal	O
failure	O
/	O
chronic	O
inflammation:	O
#	O
Iron	O
deficiency	O
#	O
B12	O
deficiency	O
Hgb	O
ranged	O
from	O
7.1	O
to	O
8.0,	O
which	O
was	O
slightly	O
lower	O
than	O
the	O
patient's	O
baseline.	O
Iron	O
studies	O
were	O
consistent	O
with	O
both	O
anemia	O
of	O
chronic	O
kidney	O
disease	O
and	O
iron	O
deficiency	O
(TSat	O
11%).	O
She	O
was	O
given	O
IV	O
iron	O
250	O
mcg	O
x2	O
prior	O
to	O
discharge.	O
Supplemental	O
B12	O
was	O
also	O
started	O
given	O
mild	O
deficiency.	O
===============	O
CHRONIC	O
ISSUES:	O
===============	O
#	O
OSA:	O
Home	O
CPAP	O
was	O
continued.	O
#	O
RA	O
(RF+/CCP+):	O
The	O
patient	O
was	O
recently	O
started	O
recently	O
on	O
Leflunomide	O
by	O
Dr.	O
___	O
while	O
inpatient.	O
Continued	O
home	O
acetaminophen.	O
#	O
Hypothyroidism:	O
TSH	O
mildly	O
elevated	O
but	O
FT4	O
normal	O
-	O
unlikely	O
the	O
etiology	O
for	O
her	O
lower	O
extremity	O
edema.	O
Patient	O
was	O
taking	O
levothyroxine	O
differently	O
than	O
prescribed	O
-	O
see	O
transitional	O
issues.	O
Continued	O
her	O
dose	O
as	O
prescribed.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
irbesartan	O
150	O
mg	O
oral	O
BID	O
2.	O
HydrALAZINE	O
75	O
mg	O
PO	O
TID	O
3.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
60	O
mg	O
PO	O
QAM	O
4.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
QPM	O
5.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
6.	O
Levothyroxine	O
Sodium	O
175	O
mcg	O
PO	O
DAILY	O
7.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
8.	O
Torsemide	O
60	O
mg	O
PO	O
BID	O
9.	O
GlipiZIDE	O
5	O
mg	O
PO	O
DAILY:PRN	O
___	O
tab	O
as	O
needed	O
up	O
to	O
ten	O
times	O
per	O
month"	O
10.	O
leflunomide	O
10	O
mg	O
oral	O
DAILY	O
11.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
12.	O
Loratadine	O
10	O
mg	O
PO	O
DAILY:PRN	O
allergies	O
13.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
14.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
15.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild	O
16.	O
ivabradine	O
5	O
mg	O
oral	O
BID	O
17.	O
Epoetin	O
___	O
___	O
unit/mL	O
SC	O
1X/WEEK	O
(FR)	O
Discharge	O
Medications:	O
1.	O
Bisacodyl	O
5	O
mg	O
PO	O
DAILY:PRN	O
Constipation	B-Constipation
-	O
First	O
Line	O
2.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
3.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
Constipation	B-Constipation
-	O
Third	O
Line	O
4.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
5.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
HS	O
6.	O
HydrALAZINE	O
100	O
mg	O
PO	O
TID	O
7.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild	O
8.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
9.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
10.	O
Epoetin	O
___	O
___	O
unit/mL	O
SC	O
1X/WEEK	O
(FR)	O
11.	O
GlipiZIDE	O
5	O
mg	O
PO	O
DAILY:PRN	O
___	O
tab	O
as	O
needed	O
up	O
to	O
ten	O
times	O
per	O
month"	O
12.	O
irbesartan	O
150	O
mg	O
oral	O
BID	O
13.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
QPM	O
14.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
60	O
mg	O
PO	O
QAM	O
15.	O
ivabradine	O
5	O
mg	O
oral	O
BID	O
16.	O
leflunomide	O
10	O
mg	O
oral	O
DAILY	O
17.	O
Levothyroxine	O
Sodium	O
175	O
mcg	O
PO	O
___	O
TABLET(87.5MCG)	O
BY	O
MOUTH	O
6	O
DAYS	O
A	O
WEEK	O
AND	O
1	O
FULL	O
TABLET	O
(175MCG)	O
ON	O
___	O
___	O
tablet(87.5mcg)	O
by	O
mouth	O
6	O
days	O
a	O
week	O
and	O
1	O
full	O
tablet	O
(175mcg)	O
on	O
___	O
18.	O
Loratadine	O
10	O
mg	O
PO	O
DAILY:PRN	O
allergies	O
19.	O
Torsemide	O
60	O
mg	O
PO	O
BID	O
20.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY	O
DIAGNOSES	O
#	O
Bilateral	O
Lower	O
Extremity	O
Edema	O
#	O
Acute	O
on	O
chronic	O
systolic	O
and	O
diastolic	O
heart	O
failure	O
#	O
CKD	O
stage	O
IV	O
#	O
Anemia	O
of	O
chronic	O
kidney	O
disease	O
#	O
Iron	O
deficiency	O
anemia	O
#	O
Vitamin	O
B12	O
deficiency	O
SECONDARY	O
DIAGNOSES	O
#	O
Obstructive	O
sleep	O
apnea	O
#	O
Rheumatoid	O
arthritis	O
#	O
Hypothyroidism	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Out	B-Mobile_with_assistance
of	B-Mobile_with_assistance
Bed	B-Mobile_with_assistance
with	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
to	B-Mobile_with_assistance
chair	B-Mobile_with_assistance
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
at	O
___.	O
WHY	O
WAS	O
I	O
ADMITTED	O
TO	O
THE	O
HOSPITAL?	O
You	O
were	O
admitted	O
because	O
your	O
feet	O
and	O
ankles	O
were	O
swollen.	O
WHAT	O
HAPPENED	O
WHILE	O
I	O
WAS	O
IN	O
THE	O
HOSPITAL?	O
We	O
gave	O
you	O
a	O
medicine	O
to	O
treat	O
the	O
swelling	O
in	O
your	O
legs	O
and	O
changed	O
some	O
of	O
your	O
home	O
medications.	O
WHAT	O
SHOULD	O
I	O
DO	O
WHEN	O
I	O
GET	O
HOME?	O
1.	O
Take	O
all	O
of	O
your	O
medications	O
as	O
prescribed	O
and	O
see	O
your	O
outpatient	O
providers	O
as	O
scheduled	O
below.	O
2.	O
Try	O
your	O
best	O
to	O
eat	O
a	O
low-salt	O
diet	O
3.	O
Weigh	O
yourself	O
every	O
morning.	O
Call	O
your	O
doctor	O
if	O
your	O
weight	O
increases	O
more	O
than	O
3	O
pounds.	O
We	O
wish	O
you	O
the	O
best!	O
Sincerely,	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

